Conformis completed the second of three milestones in its license and development agreement with Stryker Orthopaedics, under which Conformis is developing patient-specific instrumentation (PSI) for use with Stryker’s knee joint replacement implants. Conformis will receive an additional $3.0 million from Stryker for achieving this milestone.
PSI creates single-use, patient-specific instruments from a CT-based 3D model.
The collaboration, which began in late 2019, includes a long-term distribution agreement under which Conformis will supply PSI to Stryker.
“We are pleased to announce the achievement of the second project milestone,” said Mark Augusti, Conformis President and Chief Executive Officer. “We believe that this project, as well as the long-term distribution agreement under which Conformis will manufacture and supply PSI to Stryker, will create value for our shareholders as we successfully support the increasing demand for efficient outpatient joint replacement.”
Conformis completed the second of three milestones in its license and development agreement with Stryker Orthopaedics, under which Conformis is developing patient-specific instrumentation (PSI) for use with Stryker’s knee joint replacement implants. Conformis will receive an additional $3.0 million from Stryker for achieving this milestone. ...
Conformis completed the second of three milestones in its license and development agreement with Stryker Orthopaedics, under which Conformis is developing patient-specific instrumentation (PSI) for use with Stryker’s knee joint replacement implants. Conformis will receive an additional $3.0 million from Stryker for achieving this milestone.
PSI creates single-use, patient-specific instruments from a CT-based 3D model.
The collaboration, which began in late 2019, includes a long-term distribution agreement under which Conformis will supply PSI to Stryker.
“We are pleased to announce the achievement of the second project milestone,” said Mark Augusti, Conformis President and Chief Executive Officer. “We believe that this project, as well as the long-term distribution agreement under which Conformis will manufacture and supply PSI to Stryker, will create value for our shareholders as we successfully support the increasing demand for efficient outpatient joint replacement.”
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Our site uses cookies to allow easier access for Members and subscribers and to improve our site. You agree to our use of cookies by closing this message box or continuing to use our site.OkRead more
Copy to clipboard 
